Compositions, uses, kits and methods for reducing binge or compulsive eating are described herein. Methods may include administering an effective combination of a dosage of a bupropion or a pharmaceutically acceptable salt thereof, and a dosage of naltrexone or a pharmaceutically acceptable salt thereof. Methods may include identifying a patient who is overweight or obese and providing an effective combination of bupropion and naltrexone to the patient. Methods may include reducing a number of binge or compulsive eating events. Methods may include reducing severity of binge or compulsive eating events.
申请公布号
WO2012075453(A1)
申请公布日期
2012.06.07
申请号
WO2011US63170
申请日期
2011.12.02
申请人
OREXIGEN THERAPEUTICS, INC.;DUNAYEVICH, EDUARDO;MCELROY, SUSAN;LANDBLOOM, RON